High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine

OBJECTIVE: To investigate the prognostic value of derived neutrophil to lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) in patients with advanced HER2 positive breast cancer treated with trastuzumab emtansine. METHODS: Fifty one patients with advanced HER2 positive breast cancer who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Liru, Ai, Lin, Jia, Lin, Zhang, Lei, Lei, Boya, Zhang, Qingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722106/
https://www.ncbi.nlm.nih.gov/pubmed/34980025
http://dx.doi.org/10.1186/s12885-021-09131-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722106/
https://www.ncbi.nlm.nih.gov/pubmed/34980025
http://dx.doi.org/10.1186/s12885-021-09131-6

Ejemplares similares